Targeting TACE, a novel approach to the treatment of sympathetic excitation in heart failure.
靶向 TACE,一种治疗心力衰竭交感神经兴奋的新方法。
基本信息
- 批准号:10063893
- 负责人:
- 金额:$ 38.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-01-15 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdverse effectsAnimalsAnti-Inflammatory AgentsAntiinflammatory EffectAttentionAutomobile DrivingBindingBinding ProteinsBiochemistryBiological ProcessBlood - brain barrier anatomyBlood CirculationBrainBrain regionCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemCleaved cellClinicalClinical TrialsDataDiabetes MellitusDiseaseDisintegrinsEconomic BurdenElectrophysiology (science)EnzymesEquilibriumEtanerceptExhibitsFamilyFunctional disorderHeart failureHypertensionHypothalamic structureImmune responseIndustryInflammation MediatorsInflammatoryInflammatory ResponseInjectionsIntegral Membrane ProteinInterventionLeadLightMediatingMediator of activation proteinMembraneMetabolic DiseasesMetalloproteasesModelingMolecularMolecular BiologyMyocardial dysfunctionNeuraxisObesityPathogenesisPatientsPeripheralPharmacologic SubstancePharmacologyPlayProductionRattusRecombinantsResearch Project GrantsRoleSeveritiesSubfornical OrganSurvival RateSystolic heart failureTNF geneTNF-alpha converting enzymeTNFRSF1A geneTechniquesTestingTherapeuticTherapeutic InterventionTimeTissuesTumor Necrosis Factor ReceptorVentricular FunctionWorkbrain tissuecell typecytokineenzyme activityheart functionimmunocytochemistryimprovedinfliximabinsightmortalitynovelnovel strategiesnovel therapeuticsparaventricular nucleusprotective effectreceptorresponsetherapeutic cytokines
项目摘要
Heart failure (HF) is a devastating disease. Debilitation, mortality, and concomitant economic burden
associated with HF all point to the need for new therapies to address this problem more effectively. Increased
pro-inflammatory cytokines (PICs) in periphery and the central nervous system, particularly tumor necrosis
factor-α (TNF-α), have been implicated in the pathophysiology of HF. However, anti-TNF clinical trials targeting
peripheral manifestations of HF have failed to exhibit beneficial significance, indicating that the mechanisms of
TNF-α have not been challenged. Our previous study discovered that TNF-α increases in
cardiovascular/autonomic-related regions of the brain in a rat model of HF and contribute significantly to
sympathetic excitation in that setting. More recently, our preliminary data indicated that TACE, a TNF-α
converting enzyme, is upregulated in the paraventricular nucleus (PVN) of hypothalamus and subfornical organ
(SFO) of the brain, and can alter cardiovascular function and sympathetic drive in HF rats. Unlike other
cytokines, TNF-α is initially produced as a transmembrane protein (tmTNF-α). TACE is responsible for the
cleavage of tmTNF-α to release its mature form, the soluble TNF-α (sTNF-α), to mediate inflammatory and
immune responses. Further evidence indicated that sTNF-α binds predominantly to the TNF receptor 1
(TNFR1) to elicit pro-inflammatory and toxic responses and that tmTNF-α binds preferentially to the TNF
receptor 2 (TNFR2) to display an anti-inflammatory and protective role. This project will underline the role of
the brain TACE in TNF-α–induced inflammatory mechanisms driving the neurohumoral activation in HF. Using
a multifaceted approach including electrophysiology, molecular biology, immunocytochemistry, pharmacology,
and biochemistry in sham-operated and HF rats, this project will determine 1) whether TACE regulates the
balance between sTNF-α and tmTNF-α in SFO and PVN in HF, and what cell types are involved; 2) whether
increased TACE activity and/or decreased TNFR2 expression in brain contribute to the neurohumoral
excitation in HF; 3) whether inhibition of TACE or activation of TNFR2 in the brain has a beneficial effect on
cardiac function and survival rate in HF. These studies will characterize a previously unrecognized role of brain
TACE in neurohumoral activation in HF and will identify a novel anti-TNF target for pharmacological
intervention of HF. Completion of this research project will provide important insights into the anti-cytokine
therapeutic strategy in HF and may also have implications in other cardiovascular disorders like hypertension
and metabolic diseases like obesity or diabetes.
心力衰竭是一种毁灭性的疾病。虚弱、死亡和伴随而来的经济负担
与心力衰竭相关的所有问题都表明需要新的治疗方法来更有效地解决这个问题。增加了
外周和中枢神经系统中的促炎细胞因子,特别是肿瘤坏死
因子-肿瘤坏死因子(α-α)参与了心力衰竭的病理生理过程。然而,针对抗肿瘤坏死因子的临床试验
心力衰竭的外周表现没有表现出有益的意义,表明心力衰竭的机制
肿瘤坏死因子-α尚未受到挑战。我们先前的研究发现,肿瘤坏死因子-α在
在心力衰竭大鼠模型中的心血管/自主神经相关区域,并对
在那个环境中产生共鸣的兴奋。最近,我们的初步数据表明,肿瘤坏死因子-α
转换酶在下丘脑室旁核和穹隆下器上调
并能改变心力衰竭大鼠的心血管功能和交感神经动力。不同于其他
细胞因子,肿瘤坏死因子-α最初以跨膜蛋白的形式产生(tmTNF-α)。TACE负责
切割肿瘤坏死因子-α释放其成熟形式--可溶性肿瘤坏死因子-α(sTNF-α),以介导炎症和
免疫反应。进一步的证据表明,stf-α主要与ntf受体1结合。
(肿瘤坏死因子受体1)诱导促炎和毒性反应,并且tmTNF-α优先结合肿瘤坏死因子
受体2(TNFR2)具有抗炎和保护作用。该项目将强调
脑动脉化疗栓塞术在肿瘤坏死因子-α诱导的炎症机制中的作用。vbl.使用
包括电生理学、分子生物学、免疫细胞化学、药理学、
在假手术和心力衰竭大鼠中,该项目将确定1)TACE是否调节
STNF-α和tmTNF-α在SFO和PVN中的平衡,以及参与了哪些细胞类型;2)
脑内TACE活性增加和/或TNFR2表达减少与神经体液有关
3)抑制TACE或激活脑组织中的TNFR2是否具有有益的作用
心功能和存活率。这些研究将描述大脑以前未被认识到的作用
TACE对心力衰竭患者神经体液激活的影响及寻找新的抗肿瘤坏死因子的药理学靶点
心衰的干预。这项研究项目的完成将为研究抗细胞因子提供重要的见解
心力衰竭的治疗策略,并可能对高血压等其他心血管疾病也有意义
以及肥胖或糖尿病等代谢性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shunguang Wei其他文献
Shunguang Wei的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shunguang Wei', 18)}}的其他基金
Novel Role of Interleukin-17 in Sympathetic Activation in Heart Failure
IL-17 在心力衰竭交感神经激活中的新作用
- 批准号:
10094628 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Novel Role of Interleukin-17 in Sympathetic Activation in Heart Failure
IL-17 在心力衰竭交感神经激活中的新作用
- 批准号:
10327317 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Novel Role of Interleukin-17 in Sympathetic Activation in Heart Failure
IL-17 在心力衰竭交感神经激活中的新作用
- 批准号:
10542806 - 财政年份:2021
- 资助金额:
$ 38.13万 - 项目类别:
Targeting TACE, a novel approach to the treatment of sympathetic excitation in heart failure.
靶向 TACE,一种治疗心力衰竭交感神经兴奋的新方法。
- 批准号:
10306332 - 财政年份:2018
- 资助金额:
$ 38.13万 - 项目类别:
相似海外基金
Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
- 批准号:
10591918 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
- 批准号:
23K15383 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
- 批准号:
23H03556 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
- 批准号:
23K17212 - 财政年份:2023
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
- 批准号:
22H03519 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
- 批准号:
563657-2021 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10521849 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
- 批准号:
10671022 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
- 批准号:
10670918 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
- 批准号:
RGPIN-2018-04753 - 财政年份:2022
- 资助金额:
$ 38.13万 - 项目类别:
Discovery Grants Program - Individual